Hendershot Investments Inc. Sells 28 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hendershot Investments Inc. reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 665 shares of the medical equipment provider’s stock after selling 28 shares during the quarter. Hendershot Investments Inc.’s holdings in Intuitive Surgical were worth $327,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Hazlett Burt & Watson Inc. grew its stake in Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its position in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after acquiring an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC increased its holdings in Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares in the last quarter. Meeder Advisory Services Inc. raised its position in Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after purchasing an additional 22 shares during the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC boosted its stake in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,023 shares of company stock valued at $26,384,247. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Piper Sandler restated an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Citigroup increased their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Truist Financial boosted their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $541.33.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $550.41 on Friday. The stock has a 50-day moving average of $514.78 and a 200-day moving average of $472.60. Intuitive Surgical, Inc. has a one year low of $307.72 and a one year high of $556.23. The stock has a market cap of $196.05 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.